| Q39675117 | A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity |
| Q37408420 | A simple method to improve the stability of docetaxel micelles |
| Q37234202 | Advances of cancer therapy by nanotechnology |
| Q37652883 | An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation |
| Q39377073 | Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal dissemination |
| Q35091789 | Application of magnetic nanoparticles to gene delivery |
| Q38356347 | Applications of polymer micelles for imaging and drug delivery |
| Q88175987 | Biodegradable Polymeric Nanoparticles for Therapeutic Cancer Treatments |
| Q59264434 | Bioinspired nanoarchitectonics as emerging drug delivery systems |
| Q37129736 | Clinically relevant anticancer polymer Paclitaxel therapeutics |
| Q35438759 | Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical Translation |
| Q38792197 | Current Update of a Carboxymethylcellulose-PEG Conjugate Platform for Delivery of Insoluble Cytotoxic Agents to Tumors |
| Q47442172 | Design and development of multifunctional polyphosphoester-based nanoparticles for ultrahigh paclitaxel dual loading |
| Q64108949 | Development and Biological Analysis of a Novel Orthotopic Peritoneal Dissemination Mouse Model Generated Using a Pancreatic Ductal Adenocarcinoma Cell Line |
| Q26749611 | Development of polymeric micelles for targeting intractable cancers |
| Q37265495 | Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery |
| Q88965445 | Dual Acting Polymeric Nano-Aggregates for Liver Cancer Therapy |
| Q58094600 | Effects of stability of PEGylated micelles on the accelerated blood clearance phenomenon |
| Q55071436 | Emerging Therapeutic Potential of Nanoparticles in Pancreatic Cancer: A Systematic Review of Clinical Trials. |
| Q60957206 | Enhanced Anticancer Activity of 5'-DFUR-PCL-MPEG Polymeric Prodrug Micelles Encapsulating Chemotherapeutic Drugs |
| Q35674222 | Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models. |
| Q50254425 | Evaluation of a combination tumor treatment using thermo-triggered liposomal drug delivery and carbon ion irradiation |
| Q38161447 | Extracellular stability of nanoparticulate drug carriers |
| Q37351089 | Fluorescence imaging enabled biodegradable photostable polymeric micelles. |
| Q48257489 | General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes. |
| Q42379631 | Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain |
| Q34590348 | Highly stable, ligand-clustered “patchy” micelle nanocarriers for systemic tumor targeting |
| Q42158141 | Hydrophobic pharmaceuticals mediated self-assembly of beta-cyclodextrin containing hydrophilic copolymers: novel chemical responsive nano-vehicles for drug delivery. |
| Q39611679 | Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting. |
| Q58910105 | In VitroCharacterization of Pluronic F127 and D--Tocopheryl Polyethylene Glycol 1000 Succinate Mixed Micelles as Nanocarriers for Targeted Anticancer-Drug Delivery |
| Q26744830 | Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma |
| Q41880684 | Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics |
| Q30438973 | Multifunctional polymeric micelles for delivery of drugs and siRNA. |
| Q36058744 | NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo |
| Q37693046 | Nanoparticles containing insoluble drug for cancer therapy |
| Q28387499 | Nanotechnologies for noninvasive measurement of drug release |
| Q36097175 | Nanovector-based therapies in advanced pancreatic cancer |
| Q37879444 | New short interfering RNA-based therapies for glomerulonephritis |
| Q38180666 | Novozym 435-catalyzed syntheses of polyesters and polyamides of medicinal and industrial relevance |
| Q37657516 | Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle-cell interaction |
| Q37250009 | Paclitaxel Nano-Delivery Systems: A Comprehensive Review |
| Q38071668 | Paclitaxel drug delivery systems |
| Q36028787 | Perspectives on clinical translation of smart nanotherapeutics |
| Q37399257 | Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors. |
| Q84504572 | Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer |
| Q65000705 | Photo-controlled release of paclitaxel and model drugs from RNA pyramids. |
| Q35775850 | Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation |
| Q57351284 | Poly(2-oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors |
| Q36716915 | Poly(2-oxazoline)s as polymer therapeutics |
| Q38588547 | Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs. |
| Q90694715 | Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy |
| Q37319114 | Polymeric micellar delivery systems in oncology |
| Q37141404 | Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs |
| Q37679942 | Polymeric micelles as a new drug carrier system and their required considerations for clinical trials |
| Q38228138 | Polymeric micelles as drug carriers: their lights and shadows |
| Q37211504 | Polymeric micelles from poly(ethylene glycol)-poly(amino acid) block copolymer for drug and gene delivery |
| Q30478123 | Polymeric micelles in anticancer therapy: targeting, imaging and triggered release |
| Q38202058 | Polymeric micelles: nanocarriers for cancer-targeted drug delivery |
| Q38575282 | Polymeric nanoparticles: the future of nanomedicine |
| Q37975554 | Polypeptides and polyaminoacids in drug delivery |
| Q34702599 | Preparation, pharmacokinetics, biodistribution, antitumor efficacy and safety of Lx2-32c-containing liposome |
| Q49904261 | RNA-based micelles: A novel platform for chemotherapeutic drug loading and delivery |
| Q38161791 | Recent advances in amino acid N-carboxyanhydrides and synthetic polypeptides: chemistry, self-assembly and biological applications |
| Q38795892 | Sialoganglioside Micelles for Enhanced Paclitaxel Solubility: In Vitro Characterization. |
| Q38697200 | Structural modifications in polymeric micelles to impart multifunctionality for improved drug delivery |
| Q41621174 | Synthesis and self-assembly of RGD-functionalized PEO-PB amphiphiles |
| Q30940472 | Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma |
| Q35086678 | Targeted albumin-based nanoparticles for delivery of amphipathic drugs |
| Q59101713 | The Chemistry of Bioconjugation in Nanoparticles-Based Drug Delivery System |
| Q38206349 | The drug discovery by nanomedicine and its clinical experience |
| Q27693205 | The potential of polymeric micelles in the context of glioblastoma therapy |
| Q37815479 | The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting |
| Q35025984 | The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution |
| Q39945883 | Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against intracranial 9L brain tumor models. |
| Q45214606 | Translating materials design to the clinic |
| Q38177770 | What nanomedicine in the clinic right now really forms nanoparticles? |